Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

DARE Dare Bioscience Inc

0,41

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 12:16:44

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Dare Bioscience Charts.

Dare Bioscience (NASDAQ:DARE)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Dare Bioscience Charts.

News Dare Bioscience Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update
Dienstag 14 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Montag 13 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 10 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Daré Bioscience to Host First Quarter 2024 Financial Results and Company Update Conference Call and Webcast on May 14, 2024
Dienstag 7 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network
Donnerstag 2 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts
Dienstag 30 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
Dienstag 23 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Donnerstag 11 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

US Stock Futures Stable in Pre-Market On Path for Consecutive Quarterly Gains, Oil Prices Rise
Donnerstag 28 März 2024 (2 Monate vor) • IH Market News

Weitere Dare Bioscience Inc News-Artikel

Financial Select Sector

Deutsche Telekom

Energy Select Sector SPDR

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen